Vor Biopharma Inc.
VOR
$7.53
-$0.15-1.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,078.10% | -1,309.41% | 1.36% | 0.81% | 2.64% |
| Total Depreciation and Amortization | 4.89% | 27.27% | -5.23% | 1.03% | 9.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17,701.81% | 12,248.14% | 3.85% | 2.17% | -20.22% |
| Change in Net Operating Assets | 374.76% | 311.79% | 153.24% | -99.23% | -334.64% |
| Cash from Operations | -44.52% | -8.98% | 5.85% | 0.63% | -5.30% |
| Capital Expenditure | -160.82% | 30.04% | 68.23% | 78.58% | 79.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -51.63% | 34.70% | 406.50% |
| Cash from Investing | -99.91% | -99.79% | -51.46% | 36.40% | 394.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16,994.08% | 7,436.98% | 3,658.22% | 1,057.58% | -99.61% |
| Repurchase of Common Stock | 58.15% | 60.63% | 78.74% | 71.95% | 72.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -224.27% | 100.00% |
| Cash from Financing | 190,200.76% | 85,533.83% | 10,131.07% | 1,717.29% | -99.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,256.39% | 161.03% | 102.59% | 292.02% | 149.19% |